Topiramate for binge-eating disorder associated with obesity

Annals of Pharmacotherapy

Volumn 40, Issue 11, 2006, Pages 1993-1997

  Tata, Asha L ^a   Kockler, Denise R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Binge eating; Obesity; Topiramate

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TOPIRAMATE;

AMENORRHEA; BINGE EATING DISORDER; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MEDLINE; NAUSEA; NERVOUSNESS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TASTE AVERSION; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-OBESITY AGENTS; BODY WEIGHT; BULIMIA NERVOSA; FRUCTOSE; HUMANS; OBESITY;

EID: 33750978459     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H178     Document Type: Review

References (29)

1. Diagnostic and statistical manual of mental disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association, 2000.
2. Spitzer RL, Devlin M, Walsh BT, et al. Binge eating disorder a multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203.
3. Williamson DA, Martin CK, Stewart T. Psychological aspects of eating disorders. Best Pract Res Clin Gastroenterol 2004;18:1073-88.
4. Striegel-Moore RH, Franko DL. Epidemiology of binge eating disorder. Int J Eat Disord 2003;34(suppl):S19-29.
5. Stice E. Clinical implications of psychosocial research on bulimia nervosa and binge-eating disorder. J Clin Psychol 1999;55:675-83.
6. Becker AE, Grinspoon SK, Klibanski A, Herzog DB. Eating disorders. N Engl J Med 1999;340:1092-8.
7. Drewnowski A. Metabolic determinants of binge eating. Addict Behav 1995;20:733-45.
8. Mitchell JE, Mussell MP. Comorbidity and binge eating disorder. Addict Behav 1995;20:725-32.
9. Crow S, Kendall D, Praus B, Thuras P. Binge eating and other psychopathology in patients with type II diabetes mellitus. Int J Eat Disord 2001;30:222-6.
10. Zhu AJ, Walsh BT. Pharmacologic treatment of eating disorders. Can J Psychiatry 2002;47:227-34.
11. Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003;34(suppl):S74-88.
12. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998;155:1756-62.
13. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000;157:1004-6.
14. Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE. A placebo-controlled randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 2002;63;1028-33.
15. McElroy SL, Hudson JI, Malhotra S, Welge JA, Nelson EB, Keck PE. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry 2003;64:807-13.
16. Appolinario JC, Bacaltchuk J, Sichieri R, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 2003;60:1109-16.
17. Package insert. Topamax (topiramate). Titusville, NJ: Ortho McNeil Neurologics, June 2005.
18. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998;50:245-51.
19. Privitera MD. Topiramate: a new antiepileptic drug. Ann Pharmacother 1997;31:1164-73.
20. Bray GA, Hollander P, Klein S, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;1:722-33.
21. Kirov G, Tredget J. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series. BMC Psychiatry 2005;5:19.
22. Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 2004;28:1399-410.
23. Ben-Menachem E, Axelsen M, Johanson EH, Stagge A, Smith U. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003;11:556-62.
24. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 2000;61:368-72.
25. Appolinario JC, Coutinho W, Fontenelle L. Topiramate for binge-eating disorder. Am J Psychiatry 2001;158:967-8.
26. Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W. Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 2002;47:271-3.
27. Stunkard A, Berkowitz R, Tanrikut C, Cigdem BA, Reiss E, Young L. d-Fenfluramine treatment of binge eating disorder. Am J Psychiatry 1996;153:1455-9.
28. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:255-61.
29. McElroy SL, Shapira NA, Arnold LM, et al. Topiramate in the long term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 2004;65:1463-9.